Explore our curated collection of technical analyses and commercial scale-up strategies specifically focused on Chiral Beta Amino Acids. These insights are designed to support R&D and procurement teams in optimizing their supply chains.
Patent CN113755462B reveals high-activity enzyme mutants for chiral beta-amino acid synthesis, offering significant cost reduction and supply chain reliability for pharmaceutical manufacturing.
Patent CN118063351B reveals immobilized enzyme process for high-purity chiral beta-amino acids, offering cost reduction and supply chain reliability for pharmaceutical manufacturing.
Patent CN1119321C details a scalable Reformatsky route for ethyl 3S-amino-4-pentynoate, offering high optical purity and cost-effective manufacturing for pharmaceutical intermediates.